Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.94 $3.83 Thursday, 9th May 2024 CLRB stock ended at $3.24. This is 1.25% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.36% from a day low at $3.18 to a day high of $3.25.
90 days $2.94 $4.45
52 weeks $1.36 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Sep 15, 2016 $2.69 $2.92 $2.54 $2.69 100 800
Sep 14, 2016 $2.89 $2.91 $2.47 $2.75 262 300
Sep 13, 2016 $2.96 $2.96 $2.80 $2.95 134 500
Sep 12, 2016 $3.09 $3.20 $2.80 $2.99 421 500
Sep 09, 2016 $2.71 $3.20 $2.71 $3.03 774 400
Sep 08, 2016 $2.41 $3.47 $2.41 $2.77 4 137 500
Sep 07, 2016 $2.33 $2.43 $2.20 $2.39 115 700
Sep 06, 2016 $2.16 $2.46 $2.16 $2.31 71 800
Sep 02, 2016 $2.13 $2.20 $2.06 $2.16 71 600
Sep 01, 2016 $2.21 $2.25 $2.10 $2.14 56 100
Aug 31, 2016 $2.26 $2.31 $2.10 $2.18 97 000
Aug 30, 2016 $2.32 $2.41 $2.29 $2.31 55 200
Aug 29, 2016 $2.40 $2.44 $2.30 $2.34 48 800
Aug 26, 2016 $2.41 $2.44 $2.35 $2.35 49 400
Aug 25, 2016 $2.53 $2.53 $2.36 $2.44 98 400
Aug 24, 2016 $2.57 $2.68 $2.42 $2.56 96 500
Aug 23, 2016 $2.40 $2.70 $2.30 $2.59 177 800
Aug 22, 2016 $2.46 $2.55 $2.35 $2.40 110 700
Aug 19, 2016 $2.61 $2.61 $2.44 $2.49 88 100
Aug 18, 2016 $2.50 $2.54 $2.40 $2.48 130 500
Aug 17, 2016 $2.56 $2.60 $2.50 $2.53 140 400
Aug 16, 2016 $2.75 $2.80 $2.59 $2.59 119 100
Aug 15, 2016 $2.80 $2.94 $2.65 $2.75 200 000
Aug 12, 2016 $2.56 $2.98 $2.56 $2.95 208 900
Aug 11, 2016 $2.75 $2.75 $2.60 $2.68 32 400
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT